医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: A subgroup analysis from the AGITG MAX trial: An international randomised controlled trial of capecitabine, bevacizumab and mitomycin C

广告
第一作者: Price,T.J.
作者: Price,T.J. [1] ; Zannino,D. [2] ; Wilson,K. [3] ; Simes,R.J. [4] ; Cassidy,J. [5] ; Vanhazel,G.A. [6] ; Robinson,B.A. [7] ; Broad,A. [8] ; Ganju,V. [9] ; Ackland,S.P. ; Tebbutt,N.C.
作者单位: Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom [1] Department of Medical Oncology, Christchurch Hospital, Christchurch, New Zealand [2] Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, SA, Australia, Faculty of [3] Department of Medical Oncology, Geelong Hospital, Geelong, VIC, Australia [4] Department of Medical Oncology, Austin Health, Heidelberg, Australia [5] NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia [6] Department of Medical Oncology, Frankston Hospital, Frankston, VIC, Australia [7] Department of Medical Oncology, Perth Oncology, Mount Hospital, Perth, Australia [8] Department of Medical Oncology, Calvary Mater Hospital, Newcastle, VIC, Australia [9]
发布时间 2013-11-20
提交
  • 浏览0
Annals of oncology: official journal of the European Society for Medical Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷